Eva Soler‐Espejo

Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients

María José Serna, José Miguel Rivera‐Caravaca, Raquel López‐Gálvez et al. · Revista Española de Cardiología (English Edition) · 2024 · 24 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +16

Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients

José Luís Piñana, Inmaculada Heras, Tommaso Francesco Aiello et al. · Viruses · 2023 · 17 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

Laura Hurtado‐Navarro, Ernesto José Cuenca‐Zamora, Lurdes Zamora et al. · Cell Reports Medicine · 2023 · 14 citations · Full text

Life Sciences, Immunology, Oncology +17

Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation

Eva Soler‐Espejo, Beatriz Ángela Zazo-Luengo, José Miguel Rivera‐Caravaca et al. · The journal of nutrition health & aging · 2024 · 13 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy

José Luís Piñana, Lourdes Vázquez, Inmaculada Heras et al. · Frontiers in Oncology · 2024 · 11 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17